US$ 28.58
bpc 157 human clinical trials safety fda warning The just announced that they're taking steps to lift restrictions on 12 peptides — including BPC-157 and TB-500 — making them accessible through compounding pharmacies again. This is a HUGE step FDA's Overreach on Compounded Peptides
Description
Gene acquisition, duplication and metabolic specification: the evolution of fungal methylisocitrate lyases

Submitting the procedure with a diagnosis outside the covered list generates a CO-50 denial (Medical Necessity Not Met) thats rarely recoverable without an appeal

Packaging was great, shipping was prompt

The underlying clinical question has not changed